forum

PDPL Share Price Discussion

Parenteral Drugs (India) Ltd.
Sector: Pharmaceuticals and health care
... Read more
PDPL Share Price *
5.4 +0 (0%)
* (quote may be delayed)

PDPL Discussion Forum

Parenteral Drug Standalone June 2019 Net Sales at Rs 8.73 crore, down 17.55% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Parenteral Drug Consolidated June 2019 Net Sales at Rs 8.72 crore, down 82.24% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • PDPL - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization25.2
    Enterprise Value685.93
    Price to Earnings44.41
    Price to Book Value4.67
    Return on Capital Employed-0.04
    Return on Equity0.24
    Face Value10
    Dividend YieldNA
  • PDPL Share Price - Technicals

    keyboard_arrow_down
    PDPL - 52 Week High₹15.5
    PDPL - 52 Week Low₹4
  • PDPL Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jun 284.955.44.55.4
    Jun 275.55.54.655.15
    Jun 264.85.554.655.25
    Jun 255.055.54.45.2
    Jun 244.655.64.65
  • PDPL Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹5.46
    30 Day Moving Average₹5.86
    50 Day Moving Average₹6.35
    100 Day Moving Average₹7.79
    200 Day Moving Average₹8.37
  • PDPL - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue3352.19-0.37
    Operating Profit-16-34.62-0.54
    Profit Before Tax-119-125.23-0.05
    Net Income-96-113.31-0.15
  • PDPL - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds-447-4060.1
    Total Liabilities9871,170-0.16
    Total Assets539764-0.29
  • PDPL - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity14848.982.02
    Cash from Investing Activity-10.1-11
    Cash from Financing Activity-148-50.411.94
    Net Cash FlowNA-1.33-1
  • PDPL - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.13-0.12
    Return on Equity0.241.3
    Return on Capital Employed-0.04-0.09
  • PDPL - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.81
    3 Year CAGR Growth in Operating Profit-2.3
    3 Year CAGR Growth in EBIDTA-2.9
    3 Year CAGR Growth in Net Income-0.78
    3 Yr CAGR Growth - Diluted EPS-0.78
  • PDPL - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.82
    5 Year CAGR Growth in Operating Profit0.28
    5 Year CAGR Growth in EBIDTA-4.65
    5 Year CAGR Growth in Net Income-0.13
    3 Yr CAGR Growth - Diluted EPS0.02
  • PDPL Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 6 9:48 PM
    Parenteral Drug Standalone June 2019 Net Sales at Rs 8.73 crore, down 17.55% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 6 9:48 PM
    Parenteral Drug Consolidated June 2019 Net Sales at Rs 8.72 crore, down 82.24% Y-o-Y
    moneycontrol.com
    NewsBot
    Feb 15 9:37 PM
    NewsBot
    Nov 13 10:47 PM
    NewsBot
    Nov 13 10:42 PM
  • PDPL - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.